Drugs News and Research

RSS

OSA adversely affects glucose control in patients with type 2 diabetes

Obstructive Sleep Apnea (OSA) adversely affects glucose control in patients with type 2 diabetes, according to a study conducted by researchers at the University of Chicago.

18 Jan 2010

Three proteins that lead to memory loss associated with Alzheimer's disease identified

A scientific group led by the Translational Genomics Research Institute (TGen) have identified three kinases, or proteins, that dismantle connections within brain cells, which may lead to memory loss associated with Alzheimer's disease.

18 Jan 2010

Democrats reportedly settle key issues on health bill but no final accord yet

Politico reports: "President Barack Obama and senior Democratic lawmakers closed in Friday on a final health care reform package, finishing a week of intensive negotiations on tax and coverage issues that had once threatened to derail the bill.

18 Jan 2010

Longer breastfeeding can prevent postnatal HIV transmission

A new study from Zambia suggests that halting breastfeeding early causes more harm than good for children not infected with HIV who are born to HIV-positive mothers.

18 Jan 2010

Kenta Biotech and Rentschler Biotechnologie sign agreement to develop antibody against MRSA

Kenta Biotech today announced an agreement with Rentschler Biotechnologie for the development of a fully human monoclonal antibody against methicillin-resistant Staphylococcus aureus (MRSA).

18 Jan 2010

FTC wants to ban 'pay-to-delay' settlements related to generic drugs

The Associated Press/USA Today: "The Federal Trade Commission says patent settlements between drugmakers that cost U.S. consumers billions each year are on the rise. The agency reported Wednesday that the number of lucrative settlements between brand-name and generic drug companies rose to 19 last year from 16 in 2008 and 14 the year before."

18 Jan 2010

IGC scientist wins ERC grant for neuroscience research

Zachary Mainen, coordinator of the Champalimaud Foundation Neuroscience Programme at the IGC, has become one of the most recent winners of the prestigious and highly competitive European Research Council grants, to the value of 2.3 million euro, for a period of five years.

18 Jan 2010

M. D. Anderson researchers discover mechanism that helps glioblastomas evade immune attack

Cancer-initiating cells that launch glioblastoma multiforme, the most lethal type of brain tumor, also suppress an immune system attack on the disease, scientists from The University of Texas M. D. Anderson Cancer Center report in a paper featured on the cover of the Jan. 15 issue of Clinical Cancer Research.

18 Jan 2010

First genetic map of malaria drug plant could increase crop yields, study says

The first genetic map of the plant Artemisia annua, which could "help scientists develop the species into a high-yielding crop" to fight malaria, was published in a study in the journal Science on Thursday, Reuters reports (Kelland, 1/14).

18 Jan 2010

Treatment for chronic hepatitis C with pegylated-interferon and ribavirin proves effective

The current standard treatment for chronic hepatitis C with pegylated-interferon (PEG-IFN) and ribavirin is effective in approximately 50%-60% of patients, so that a substantial proportion of patients remain unresponsive.

18 Jan 2010

New class of drugs could help prevent skin cancer

A new study by Loyola University Health System researchers could lead to alternative treatments that would shrink skin cancer tumors with drugs. The drugs would work by turning on a gene that prevents skin cells from becoming cancerous, said senior author Mitchell Denning, Ph.D.

18 Jan 2010

Study raises concerns about drug-resistant HIV

The emergence of drug-resistant strains of HIV could one day threaten efforts to control the global HIV pandemic, according to a study published online Thursday in the journal Science, HealthDay News/U.S. News & World Report reports. The researchers based their findings on "a mathematical model that tracks the transmission of multiple strains of HIV" in San Francisco, the news service writes (1/14).

18 Jan 2010

Results from Bionovo's phase 1B clinical trial of Bezielle published

Bionovo, Inc. announced today the publication of their results from its phase 1B clinical trial of Bezielle (BZL101) for metastatic breast cancer. The results of the study are available online in Breast Cancer Research and Treatment and demonstrate that Bezielle continues to be safe and well tolerated with clinical evidence of anticancer activity in a heavily pretreated population of women diagnosed with metastatic breast cancer.

17 Jan 2010

ALAC to release annual State of Tobacco Control report card for the state of California

American Lung Association in California (ALAC) joined civic leaders, medical professionals and local residents of the city of Richmond to release its annual State of Tobacco Control report card for cities and counties throughout the state of California.

13 Jan 2010

Law enforcement and community activists join hands to support anti-marijuana cause

With President Obama leading the charge against legalization of marijuana in what he calls a "new era of responsibility," a cultural change is taking place in California as more and more community activists join law enforcement officers, former drug addicts and faith-based leaders in support of the anti-marijuana cause.

13 Jan 2010

Era of rapid expansion in biomedical research funding began in 1990's ends

After a decade of remarkable growth, total annual funding for biomedical research in the U.S. has decelerated and may have even fallen when adjusted for inflation. That is the conclusion of a study today published in the Journal of the American Medical Association.

13 Jan 2010

NCCN to present recommendations on REMS in cancer care at Oncology Summit

Risk evaluation and mitigation strategies (REMS), which can be required by the FDA for drugs or biologics with significant toxicity and/or risks, are emerging as a priority topic for a variety of individuals. The goal of REMS to mitigate known or potential drug risks must be balanced with concerns that such programs may be overly complex and burdensome to physicians and other healthcare providers.

13 Jan 2010

Sudden deaths attributed to cocaine use; drug remains a growing health problem in Europe

Forensic pathologists have shown that over three per cent of all sudden deaths in south-west Spain are related to the use of cocaine. They believe their findings can be extrapolated to much of the rest of Europe, indicating that cocaine use is a growing public health problem in Europe and that there is no such thing as "safe" recreational use of small amounts of the drug.

13 Jan 2010

Scripps Research scientists produce chemically complex compound

In 1993 researchers discovered a chemical compound in a sponge off Palau, an island nation in the Pacific Ocean, that has shown anticancer, antibacterial, and antifungal pharmaceutical promise. But that wasn't its greatest allure, at least not for chemists.

13 Jan 2010

ERA-NET PathoGenoMics announces third international joint call for infectious disease research

ERA-NET PathoGenoMics, an initiative of the European Commission aimed at advancing transnational genome-based research programs on human-pathogenic microorganisms, announced today the third international joint call. The third joint call allocated €8.5 Million over 3 years to relevant research projects which will be provided by ERA-NET PathoGenoMics partner organizations from Austria, France, Germany, Hungary, Israel, Portugal, Slovenia and Spain.

13 Jan 2010

Drugs News and Research

OSA adversely affects glucose control in patients with type 2 diabetes

Three proteins that lead to memory loss associated with Alzheimer's disease identified

Democrats reportedly settle key issues on health bill but no final accord yet

Longer breastfeeding can prevent postnatal HIV transmission

Kenta Biotech and Rentschler Biotechnologie sign agreement to develop antibody against MRSA

FTC wants to ban 'pay-to-delay' settlements related to generic drugs

IGC scientist wins ERC grant for neuroscience research

M. D. Anderson researchers discover mechanism that helps glioblastomas evade immune attack

First genetic map of malaria drug plant could increase crop yields, study says

Treatment for chronic hepatitis C with pegylated-interferon and ribavirin proves effective

New class of drugs could help prevent skin cancer

Study raises concerns about drug-resistant HIV

Results from Bionovo's phase 1B clinical trial of Bezielle published

ALAC to release annual State of Tobacco Control report card for the state of California

Law enforcement and community activists join hands to support anti-marijuana cause

Era of rapid expansion in biomedical research funding began in 1990's ends

NCCN to present recommendations on REMS in cancer care at Oncology Summit

Sudden deaths attributed to cocaine use; drug remains a growing health problem in Europe

Scripps Research scientists produce chemically complex compound

ERA-NET PathoGenoMics announces third international joint call for infectious disease research

Drug Discovery - Second Edition eBook

Leveraging the power of automation to boost research

Automating research - solutions and best practices

How can microdialysis benefit drug development

Latest News